Substance P Dosage Guide

Complete guide to Substance P dosing protocols, administration methods, and safety considerations for research purposes.

Research Use Only: The dosage information provided is for educational and research purposes. Peptides are not approved by the FDA for human use. Always consult with a healthcare professional.

Recommended Dosage

Not used as a therapeutic agent. NK1 receptor antagonists (blocking Substance P) are used clinically for chemotherapy-induced nausea.

Administration Method

Research compound only. Therapeutic applications focus on blocking rather than administering Substance P.

Side Effects to Monitor

Administration would cause pain, inflammation, and neurogenic responses. Not given therapeutically.

Safety Considerations & Risks

Exogenous administration would be harmful. Research focuses on antagonists not agonists.